A large number of HIV-1 integrase (IN) alterations, referred to as class II substitutions, exhibit 28 pleotropic effects during virus replication. However, the underlying mechanism for the class II 29 phenotype is not known. Here we demonstrate that all tested class II IN substitutions 30 compromised IN-RNA binding in virions by one of three distinct mechanisms: i) markedly 31 reducing IN levels thus precluding formation of IN complexes with viral RNA; ii) adversely 32 affecting functional IN multimerization and consequently impairing IN binding to viral RNA; iii) 33 directly compromising IN-RNA interactions without substantially affecting IN levels or functional 34 IN multimerization. Inhibition of IN-RNA interactions resulted in mislocalization of the viral 35 ribonucleoprotein complexes outside the capsid lattice, which led to premature degradation of 36 the viral genome and IN in target cells. Collectively, our studies uncover causal mechanisms for 37 the class II phenotype and highlight an essential role of IN-RNA interactions for accurate virion 38 maturation. 39 40 42 between the HIV-1 Gag and Gag-Pol polyproteins, and the viral RNA (vRNA) genome. At the 43 plasma membrane of an infected cell, Gag and Gag-Pol molecules assemble around a vRNA 44 dimer and bud from the cell as a spherical immature virion, in which the Gag proteins are 45 radially arranged [1-3]. As the immature virion buds, the viral protease enzyme is activated and 46 cleaves Gag and Gag-Pol into their constituent domains triggering virion maturation [1, 2].
INTRODUCTION

41
Infectious HIV-1 virions are formed in a multistep process coordinated by interactions Immunoblotting 154 Viral and cell lysates were resuspended in sodium dodecyl sulfate (SDS) sample buffer and 155 separated by electrophoresis on Bolt 4-12% Bis-Tris Plus gels (Life Technologies), blotted onto 156 nitrocellulose membranes and probed overnight at 4°C with the following antibodies in Odyssey transfected with a derivative of the full-length HIV-1 NL4-3 proviral plasmid bearing a class I IN HEK293T cells grown on 10-cm dishes were transfected with 10 µg pNL4-3 plasmid DNA 205 containing the WT sequence or indicated pol mutations within IN coding sequence. Two days 206 post-transfection cell-free virions collected from cell culture supernatants were pelleted by 207 ultracentrifugation through a 20% sucrose cushion using a Beckman SW41-Ti rotor at 28,000 208 rpm for 1.5 h at 4°C. Pelleted virions were resuspended in 1X PBS and treated with ethylene 209 glycol bis(succinimidyl succinate) (EGS) (ThermoFisher Scientific), a membrane permeable 210 crosslinker, at a concentration of 1 mM for 30 min at room temperature. Crosslinking was 211 stopped by addition of SDS sample buffer. Samples were subsequently separated on 3-8% Tris-212 acetate gels and analyzed by immunoblotting using a mouse monoclonal anti-IN antibody [69] .
213
Size exclusion chromatography (SEC)
214
All of the mutations were introduced into a plasmid backbone expressing His 6 tagged pNL4-3-215 derived IN by QuikChange site directed mutagenesis kit (Agilent) [60] . His 6 tagged recombinant 216 pNL4-3 WT and mutant INs were expressed in BL21 (DE3) E. coli cells followed by nickel and 217 heparin column purification as described previously [60, 73] . Recombinant WT and mutant INs 218 were analyzed on Superdex 200 10/300 GL column (GE Healthcare) with running buffer 219 containing 20 mM HEPES (pH 7.5), 1 M NaCl, 10% glycerol and 5 mM BME at 0.3 mL/min flow 220 rate. The proteins were diluted to 10 µM with the running buffer and incubated for 1 h at 4°C 221 followed by centrifugation at 10,000g for 10 min. Multimeric form determination was based on 222 the standards including bovine thyroglobulin (670,000 Da), bovine gamma-globulin (158,000 223 Da), chicken ovalbumin (44,000 Da), horse myoglobin (17,000 Da) and vitamin B12 (1,350 Da).
224
Analysis of IN-RNA binding in vitro 225
Following SEC of IN as above, individual fractions of tetramer, dimer and monomer forms were 226 collected and their binding to TAR RNA was analyzed by an Alpha screen assay as described 227 previously [28] . Briefly, 100 nM His 6 tagged IN fractions (tetramer, dimer and monomer) were was incubated with streptavidin donor beads in buffer containing 100 mM NaCl, 1 mM MgCl 2 , 1 230 mM DTT, 1 mg/mL BSA, 25 mM Tris (pH 7.4) . Followed by 2-h incubation at 4°C, they were 231 mixed and the reading was taken after 1 h incubation at 4°C by PerkinElmer Life Sciences
232
Enspire multimode plate reader. The Kd values were calculated using OriginLab software.
233
Virus production and transmission electron microscopy 234 Cell-free HIV-1 virions were isolated from transfected HEK293T cells. Briefly, cells grown in two 235 15-cm cell culture plates (10 7 cells per dish) were transfected with 30 µg full-length proviral 236 plasmid (pNL4-3) DNA containing the WT sequence or indicated pol mutations within IN coding 237 sequence using PolyJet DNA transfection reagent as recommended by the manufacturer 238 (SignaGen Laboratories). Two days after transfection, cell culture supernatants were filtered 239 through 0.22 µm filters and pelleted by ultracentrifugation using a Beckman SW32-Ti rotor at 240 26,000 rpm for 2 h at 4 o C. Fixative (2.5% glutaraldehyde, 1.25% paraformaldehyde, 0.03% 241 picric acid, 0.1 M sodium cacodylate, pH 7.4) was gently added to resulting pellets, and samples 242 were incubated overnight at 4 o C. The following steps were conducted at the Harvard Medical 243 School Electron Microscopy core facility. Samples were washed with 0.1 M sodium cacodylate, 244 pH 7.4 and postfixed with 1% osmium tetroxide /1.5% potassium ferrocyanide for 1 h, washed 245 twice with water, once with maleate buffer (MB), and incubated in 1% uranyl acetate in MB for 1 246 h. Samples washed twice with water were dehydrated in ethanol by subsequent 10 minute 247 incubations with 50%, 70%, 90%, and then twice with 100%. The samples were then placed in 248 propyleneoxide for 1 h and infiltrated overnight in a 1:1 mixture of propyleneoxide and TAAB 249 Epon (Marivac Canada Inc.). The following day the samples were embedded in TAAB Epon and 250 polymerized at 60 °C for 48 h. Ultrathin sections (about 60 nm) were cut on a Reichert Ultracut-251 S microtome, transferred to copper grids stained with lead citrate, and examined in a JEOL
252
1200EX transmission electron microscope with images recorded on an AMT 2k CCD camera.
Images were captured at 30,000x magnification, and over 100 viral particles per sample were 254 counted by visual inspection.
255
Equilibrium density sedimentation of virion core components in vitro 256
Equilibrium density sedimentation of virion core components was performed as previously 257 described [64] . Briefly, HEK293T cells grown in 10-cm cell culture plates were transfected with 258 10 µg pNLGP plasmid DNA containing the WT sequence or indicated pol mutations within IN 259 coding sequence. Two days post-transfection cell-free virions collected from cell culture 260 supernatants were pelleted by ultracentrifugation through a 20% sucrose cushion using a 261 Beckman SW41-Ti rotor at 28,000 rpm for 1.5 hr at 4°C. Pelleted viral-like particles were 262 resuspended in PBS and treated with 0.5% Triton X-100 for 2 min at room temperature.
263
Immediately after, samples were layered on top of 30-70% linear sucrose gradients prepared in 264 1X STE buffer (100 mM NaCl, 10 mM Tris-Cl (pH 8.0), 1 mM EDTA) and ultracentrifuged using 265 a Beckman SW55-Ti rotor at 28,500 rpm for 16 h at 4°C. Fractions (500 µL) collected from the 266 top of the gradients were analyzed for IN, CA, and MA by immunoblotting as detailed above.
267
Biochemical analysis of virion core components in infected cells
268
Biochemical analysis of retroviral cores in infected cells was performed as described previously 269 [74] . Briefly, pgsA-745 cells were infected with VSV-G pseudotyped single cycle GFP-reporter 270 viruses or its derivatives synchronously at 4°C. Following the removal of virus inoculum and 271 extensive washes with PBS, cells were incubated at 37°C for 2 h. To prevent loss of vRNA due 272 to reverse-transcription, cells were infected in the presence of 25 µM nevirapine. Post-nuclear 273 supernatants were separated by ultracentrifugation on 10-50% linear sucrose gradients using a 274 Beckman SW55-Ti rotor at 30,000 rpm for 1 h at 4°C. Ten 500 µl fractions from the top of the 
281
VSV-G pseudotyped HIV-1 NL4-3 virus stocks were prepared as described above and 282 concentrated 40X using a lentivirus precipitation solution (ALSTEM). PgsA-745 cells were 283 plated on 1.5 mm collagen-treated coverslips (GG-12-1.5-Collagen, Neuvitro) placed in 24-well 284 plates one day prior to infection. Synchronized infections were performed by incubating pre-285 chilled virus inoculum on the cells for 30 min at 4°C. Cells were infected with WT virus at a MOI 286 of 0.5, or with an equivalent number (normalized by RNA copy number) of IN mutant viral 287 particles. After removal of the virus inoculum cells were washed with PBS and either 288 immediately fixed with 4% paraformaldehyde, or incubated at 37°C for 2 h before fixing. To 289 prevent loss of vRNA due to reverse-transcription, cells were infected and incubated in the 290 presence of 25 µM nevirapine. Following fixation, cells were dehydrated with ethanol and stored 291 at -20°C. Prior to probing for vRNA, cells were rehydrated, incubated in 0.1% Tween in PBS for 292 10 min, and mounted on slides. Probing was performed using RNAScope probes and reagents 293 (Advanced Cell Diagnostics). Briefly, coverslips were treated with protease solution for 15 min in 294 a humidified HybEZ oven (Advanced Cell Diagnostics) at 40 °C. The coverslips were then 295 washed with PBS and pre-designed anti-sense probes [75] specific for HIV-1 vRNA were 296 applied and allowed to hybridize with the samples in a humidified HybEZ oven at 40 °C for 2 h.
297
The probes were visualized by hybridizing with preamplifiers, amplifiers, and finally, a 298 fluorescent label. First, pre-amplifier 1 (Amp 1-FL) was hybridized to its cognate probe for 30 299 min in a humidified HybEZ oven at 40 °C. Samples were then subsequently incubated with Amp 300 2-FL, Amp 3-FL, and Amp 4A-FL for 15 min, 30 min, and 15 min respectively. Between adding 301 amplifiers, the coverslips were washed with a proprietary wash buffer. Nuclei were stained with 302 DAPI diluted in PBS at room temperature for 5 min. Finally, coverslips were washed in PBST Images were taken using a Zeiss LSM 880 Airyscan confocal microscope equipped with a 306 ×63/1.4 oil-immersion objective using the Airyscan super-resolution mode. 10 images were 307 taken for each sample using the ×63 objective. Numbers of nuclei and vRNA punctae in images 308 were counted using Volocity software (Quorum Technologies). The number of vRNA punctae 309 per 100 nuclei were recorded at 0 h post-infection (hpi) and 2 hpi for each virus, and the number 310 at 2 hpi compared to the number at 0 hpi.
311
Analysis of the fate of vRNA genome in MT4 cells
312
MT-4 cells were infected with VSV-G pseudotyped HIV-1 NL4-3 WT or equivalent number of 313 mutant viruses (normalized by RT activity) synchronously at 4°C. After removal of virus 314 inoculum and extensive washes with PBS, cells were incubated at 37°C for 6 h in the presence 315 of 25 µM nevirapine. Immediately after synchronization (0 h) and at 2 and 6 h post-infection 316 samples were taken from the infected cultures and RNA was isolated using TRIzol Reagent.
317
The amount of viral genomic RNA was measured by Q-RT-PCR.
319
RESULTS
320
Characterization of the replication defects of class II IN mutant viruses
321
Substitutions in IN that exhibited a class II phenotype (i.e. assembly, maturation or 322 reverse transcription defects [10-44, 76, 77] or affected IN multimerization [46, [78] [79] [80] [81] were 323 selected from past literature. The location of these substitutions depicted on the cryo-EM 324 structure of the tetrameric HIV-1 intasome complex [9] indicate that many are positioned at or 325 near monomer-monomer or dimer-dimer interfaces ( Fig. 1A-B ). While not apparent in the 326 tetrameric intasome complex, the CTD mediates IN tetramer-tetramer interactions in the higher-327 order dodecamer IN structure [9] and has also been shown to mediate IN multimerization in vitro IN mutations were introduced into the replication competent pNL4-3 molecular clone and 330 HEK293T cells were transfected with the resulting plasmids. Cell lysates and cell-free virions 331 were subsequently analyzed for Gag/Gag-Pol expression, processing, particle release and 332 infectivity. While substitutions in IN had no measurable effect on Gag (Pr55) expression, modest 333 effects on Gag processing in cells was visible for several missense mutant viruses including 334 H12N, N18I, K34A, Y99A, K103E, W108R, F185K, Q214L/Q216L, L242A, V260E, as well as 335 the ΔIN mutant ( Fig. 2A ). Nevertheless, particle release was largely similar between WT and IN 336 mutant viruses, as evident by the similar levels of CA protein present in cell culture supernatants 337 ( Fig. 2A , lower panels).
338
Three distinct phenotypes became apparent by assessing the amount of virion-339 associated IN and RT enzymes ( Fig. 2A and Fig. S1A ). First, virion-associated IN was at least 340 5-fold less than WT with several mutants, including H12N, N18I, K103E, W108R, F185K,
341
L242A, and V260E ( Fig. 2A and Table 1 ). Notably, these substitutions also reduced levels of 342 Gag-Pol processing intermediates in producer cells ( Fig. 2A ) and RT in virions ( Fig 
380
IN-vRNA complexes were immunoprecipitated from UV-crosslinked virions and the 381 levels of coimmunoprecipitating vRNA was assessed. Note that substitutions that significantly 382 reduced the amount of IN in virions ( Fig. 2A , Table 1 ) were excluded from these experiments.
383
All class II IN mutant viruses contained similar levels of vRNA, ruling out any inadvertent effects 
397
species that migrated at molecular weights consistent with those of monomers, dimers, trimers 398 and tetramers were readily distinguished in WT virions (Fig. 4A ). In the majority of the class II 399 mutant particles, IN appeared to be predominantly monomeric, with little dimers and no readily 400 detectable tetramers (Fig. 4A) . In contrast to this general pattern, K34A, E96A, R262A/R263A 4A). An undefined smear was present at higher molecular weights for all virions, possibly as a 403 result of the formation of large IN aggregates upon cross-linking ( Fig. 4A ).
404
To corroborate these findings, we analyzed the multimerization properties of 405 recombinant WT, K34A, E96A, K188E, K236A and R262A/R263A IN proteins by SEC ( Fig. 4B ).
406
In line with the crosslinking studies in virions, WT, K34A and R262A/R263A IN molecules all 407 formed tetramers, while the levels of dimers varied between the mutants. 
423
Collectively, these results pointed to a key role of IN tetramerization in RNA binding and 424 suggest that a defect in proper multimerization underlies the inability of the majority of class II IN tetramerization, our findings suggest that these residues may be directly involved in IN binding 427 to RNA.
428
Class II IN substitutions generate virions with eccentric morphology
429
We next sought to determine how preclusion or inhibition of IN-vRNA interactions 430 correlated with particle morphology. Virion morphology of a subset of the IN mutants that envelope by brief detergent treatment were separated on sucrose gradients, and resulting before [64], WT IN migrated primarily in dense fractions, whereas the R269A/K273A mutant 452 migrated bimodally (Fig. 6A, B) . In contrast to our hypothesis, the majority of IN mutants 453 sedimented similarly to WT IN and settled in the denser gradient fractions (Fig. 6A, B ).
454
Exceptions were the K34A and R262A/R263A IN mutants, a fraction of which migrated in 
467
IN molecules appeared to remain associated with higher-order CA in virions ( Fig. 6 ), we also 468 wanted to test whether they would be protected from premature degradation in infected cells.
469
The fates of viral core components in target cells were tracked using a previously 470 described biochemical assay [74] . For these experiments we utilized pgsA-745 cells (pgsA), 471 which lack surface glycosaminoglycans, and likely as a result can be very efficiently infected by 
504
Finally, we tested whether our findings held true in physiologically relevant human cells.
505
MT-4 T cells were synchronously infected with WT or class II IN mutant VSV-G pseudotyped
506
HIV-1 NL4-3 in the presence of nevirapine. Cells were collected immediately after synchronization 507 (0 h), 2 and 6 h post-infection, and the quantity of vRNA measured by Q-PCR. In line with the 508 above findings, vRNA levels decreased at a faster rate with the class II IN mutants as compared 509 to WT viruses, with half as much cell-associated vRNA remaining at 2 and 6 h post-infection for 510 the class II IN mutants (Fig. 7G ). Treating cells with ammonium chloride to prevent fusion of the 511 VSV-G pseudotyped viruses rescued vRNA loss, and vRNA from WT and mutant viruses were 512 retained at equal levels, indicating that the loss of vRNA is dependent on entry into the target 513 cell (Fig. S2D) . These findings agree with the previous experiments and demonstrate that class cells. We provide evidence that premature degradation of the exposed vRNPs and separation of Taken together, our findings cement the view that IN binding to RNA accounts for the role of IN 528 in accurate particle maturation and provide the mechanistic basis of why these viruses are 529 blocked at reverse transcription in target cells.
530
In regard to the first case (i) above, it was previously shown that IN deletion leads to the 531 formation of eccentric particles [11, 27] . Thus, it is reasonable to assume that missense 532 mutations that decreased IN levels in virions phenocopy IN deletion viruses. While it is also 533 possible that these substitutions additionally affected IN binding to vRNA or multimerization, we 534 could not reliably address these possibilities due to the extremely low levels of these proteins in 535 virions.
536
Our results show the striking affinity of IN tetramers to bind RNA compared with IN 537 monomers and dimers (Fig. 4C ). In support of tetramerization being a prerequisite for RNA-538 binding, the inability of a number of class II IN mutant proteins to bind RNA was accompanied 539 by a clear multimerization defect both in virions ( Fig. 4A ) and in vitro (Fig. 4B) 
546
Based on MS-based footprinting experiments in vitro, we previously found that positively 547 charged residues within the CTD of IN (i.e. K264, K266, K273) directly contact RNA, as was 548 also validated by CLIP experiments [28] . Our findings here suggest that IN-vRNA contacts may 549 extend to nearby basic residues within the CTD, such as R262 and R263, and perhaps more 550 surprisingly, K34 within the IN NTD, as alterations of these residues did not prevent IN reduced RNA-binding in vitro ( Fig 4D) . This raises the possibility of a second RNA-binding site 553 in the IN NTD. Structural analysis of IN in complex with RNA will be essential to definitively 554 determine how IN binds RNA as well as the precise multimeric species required for binding.
555
The mechanism by which IN-vRNA interactions mediate the encapsidation of vRNPs 556 inside the CA lattice remains unknown. One possibility is that the temporal coordination of 557 proteolytic cleavage events during maturation is influenced by 87] . In [64] . In this study, only two class II IN mutants (K34A and R262A/R263A) revealed this 573 phenotype (Fig. 6A, B) . It is intriguing that the bimodal distribution of IN in this experimental 574 setting was only seen with IN mutants that directly inhibited IN binding to vRNA. A possible 575 explanation for these observations is that improperly multimerized IN is retained within the CA E87A and V165A mutant INs were rapidly lost in infected cells, suggesting that they are not fully 578 protected by CA upon cellular entry (Fig. 7C ).
579
Why is the unprotected vRNA and IN prematurely lost in target cells? It seems evident 580 that the protection afforded by the CA lattice matters the most for vRNP stability, though we 581 cannot rule out that IN binding to vRNA may in and of itself stabilize both the genome and IN.
582
Alternatively, the AU-rich nucleotide content of HIV-1 may destabilize its RNA [88-90], similar to 583 several cellular mRNAs that encode for cytokines and growth factors [91] . Finally, RNA nicking 584 and deadenylation in virions by virion associated enzymes [92-94] may predispose retroviral 585 genomes to degradation when they are prematurely exposed to the cytosolic milieu. While 
591
In conclusion, we have identified IN-vRNA binding as the underlying factor for the role of Figure S2 
